Becker's Healthcare July 8, 2025
Rylee Wilson

Tools that allow providers to see prescription cost estimates at the time of prescribing did not have any effect on cost, a study published July 3 in JAMA Network Open found.

The cohort study included 2.8 million Medicare Advantage beneficiaries at a national insurer. Researchers compared differences in prescription drug spending and fills in the year after practices adopted a real time prescription benefit drug tool.

Here are three things to know:

  1. The researchers found no significant difference between out-of-pocket spending or total prescription costs per beneficiary after their providers implemented real-time prescription benefit tools.
  2. Real-time prescription benefit tools did not increase...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Insurance, Medicare Advantage, Provider, Survey / Study, Trends
CMS Signals MA Payment Slowdown as Provider Frustration With The Plans Continue to Mount
CMS proposes excluding chart reviews from MA risk scoring in 2027 payment rule
CMS proposes nearly flat Medicare Advantage payments for 2027: 6 notes
Sick of Fighting Insurers, Hospitals Offer Their Own Medicare Advantage Plans
How Risk Adjustment Affects Payment for Medicare Advantage Plans

Share Article